- Home
- EBS vs EHAB Comparison
EBS vs EHAB Comparison
Compare EBS & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- EHAB
- Stock Information
- Founded
- EBS 1998
- EHAB 2014
- Country
- EBS United States
- EHAB United States
- Employees
- EBS N/A
- EHAB N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- EHAB Hospital/Nursing Management
- Sector
- EBS Health Care
- EHAB Health Care
- Exchange
- EBS Nasdaq
- EHAB Nasdaq
- Market Cap
- EBS 423.6M
- EHAB 409.1M
- IPO Year
- EBS 2006
- EHAB N/A
- Fundamental
- Price
- EBS $9.14
- EHAB $8.13
- Analyst Decision
- EBS Strong Buy
- EHAB Buy
- Analyst Count
- EBS 2
- EHAB 3
- Target Price
- EBS $13.50
- EHAB $8.67
- AVG Volume (30 Days)
- EBS 959.0K
- EHAB 390.2K
- Earning Date
- EBS 11-05-2025
- EHAB 11-05-2025
- Dividend Yield
- EBS N/A
- EHAB N/A
- EPS Growth
- EBS N/A
- EHAB N/A
- EPS
- EBS 2.53
- EHAB N/A
- Revenue
- EBS $851,600,000.00
- EHAB $1,037,800,000.00
- Revenue This Year
- EBS N/A
- EHAB $4.95
- Revenue Next Year
- EBS $19.24
- EHAB $4.33
- P/E Ratio
- EBS $3.62
- EHAB N/A
- Revenue Growth
- EBS N/A
- EHAB N/A
- 52 Week Low
- EBS $4.02
- EHAB $6.47
- 52 Week High
- EBS $12.73
- EHAB $10.91
- Technical
- Relative Strength Index (RSI)
- EBS 65.40
- EHAB 55.01
- Support Level
- EBS $8.58
- EHAB $7.93
- Resistance Level
- EBS $9.34
- EHAB $8.21
- Average True Range (ATR)
- EBS 0.38
- EHAB 0.23
- MACD
- EBS 0.10
- EHAB -0.00
- Stochastic Oscillator
- EBS 85.94
- EHAB 69.77
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.